We are live on ! Find out more
Cetera Investment Advisers

Cetera Investment Advisers Portfolio holdings

AUM $94B
1-Year Est. Return 20.14%
This Fund
S&P 500
This Quarter Est. Return
+2.47%
1 Year Est. Return
+20.14%
3 Year Est. Return
+58.25%
5 Year Est. Return
+64.18%
10 Year Est. Return
+205.32%
AUM
$43.4B
AUM Growth
+$1.03B
Cap. Flow
+$302M
Cap. Flow %
0.69%
Top 10 Hldgs %
17.79%
Holding
3,897
New
201
Increased
1,772
Reduced
1,648
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 10.86%
2 Financials 4.08%
3 Consumer Discretionary 3.6%
4 Healthcare 3.52%
5 Industrials 2.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PTON icon
3501
Peloton Interactive
PTON
$2.42B
$96.1K ﹤0.01%
28,425
-8,571
-23% -$30.7K
VOC icon
3502
VOC Energy
VOC
$54.1M
$95.7K ﹤0.01%
19,889
-560
-3% -$3.14K
OIA icon
3503
Invesco Municipal Income Opportunities Trust
OIA
$290M
$94.9K ﹤0.01%
14,943
-7,718
-34% -$48.4K
BTE icon
3504
Baytex Energy
BTE
$3.06B
$94.3K ﹤0.01%
27,096
TMCI icon
3505
Treace Medical Concepts
TMCI
$303M
$93.1K ﹤0.01%
+13,999
New +$113K
BYND icon
3506
Beyond Meat
BYND
$268M
$93.1K ﹤0.01%
13,872
-465
-3% -$3.3K
PYXS icon
3507
Pyxis Oncology
PYXS
$243M
$93K ﹤0.01%
28,110
-1,250
-4% -$5.25K
TSI
3508
TCW Strategic Income Fund
TSI
$213M
$92.3K ﹤0.01%
19,471
+9,029
+86% +$42K
CIFR icon
3509
Cipher Digital
CIFR
$6.78B
$91.7K ﹤0.01%
22,085
+250
+1% +$1.03K
EGY icon
3510
Vaalco Energy
EGY
$622M
$90.7K ﹤0.01%
14,472
-704
-5% -$4.54K
CRDF icon
3511
Cardiff Oncology
CRDF
$80.1M
$89.9K ﹤0.01%
+40,500
New +$153K
ADT icon
3512
ADT
ADT
$5.49B
$89.9K ﹤0.01%
11,826
+176
+2% +$1.22K
MD icon
3513
Pediatrix Medical
MD
$2.12B
$89.5K ﹤0.01%
+11,852
New +$98K
ONL
3514
Orion Office REIT
ONL
$156M
$88.9K ﹤0.01%
24,777
+697
+3% +$2.39K
EDF
3515
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$170M
$88.8K ﹤0.01%
16,852
+1,153
+7% +$6.23K
AIV
3516
Aimco
AIV
$377M
$88.1K ﹤0.01%
10,631
+154
+1% +$1.24K
AAOI icon
3517
Applied Optoelectronics
AAOI
$11.2B
$87K ﹤0.01%
+10,500
New +$115K
ALT icon
3518
Altimmune
ALT
$593M
$86.7K ﹤0.01%
13,032
-52,304
-80% -$386K
SILV
3519
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$85.9K ﹤0.01%
10,517
-4,353
-29% -$35.5K
ECF
3520
Ellsworth Growth & Income Fund
ECF
$173M
$85.9K ﹤0.01%
10,423
-932
-8% -$7.45K
SELF
3521
Global Self Storage
SELF
$59.5M
$85.7K ﹤0.01%
17,638
-2,573
-13% -$12K
ADTN icon
3522
Adtran
ADTN
$622M
$85.3K ﹤0.01%
+16,208
New +$82.6K
GENI icon
3523
Genius Sports
GENI
$2.1B
$84.6K ﹤0.01%
+15,517
New +$82.9K
TDF
3524
Templeton Dragon Fund
TDF
$281M
$84.1K ﹤0.01%
10,482
-1,900
-15% -$15.6K
BGC icon
3525
BGC Group
BGC
$4.86B
$83.9K ﹤0.01%
+10,103
New +$83.2K

Similar funds

Cetera Investment Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Cetera Investment Advisers held 3,897 positions worth $43.4B, up 2.4% from $42.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cetera Investment Advisers's Q2 2024 filing shows 201 new, 1,772 increased, 1,648 reduced and 173 closed positions. Its largest new stake was Capital Group Core Balanced ETF: 400,367 shares worth $11.9M. The largest sale was Apple, an estimated $162M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cetera Investment Advisers's largest Q2 2024 buy was Capital Group Core Balanced ETF: 400,367 shares worth $11.9M.
  • Cetera Investment Advisers added most to iShares S&P 500 Growth ETF in Q2 2024, an estimated $66.8M increase.
  • Cetera Investment Advisers's biggest Q2 2024 reduction was Apple, cutting an estimated $162M.
  • Cetera Investment Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $9.75M.
  • Cetera Investment Advisers's ten largest holdings make up 18% of its $43.4B portfolio in Q2 2024.
  • Cetera Investment Advisers opened 201 new positions and closed 173 in Q2 2024.
  • Cetera Investment Advisers's portfolio value rose 2.4% quarter-over-quarter to $43.4B.

Based on Cetera Investment Advisers's 13F filing for Q2 2024, filed 22 Aug 2024.